Dyspareunia and Central Sensitization
Endometriosis Deep Dyspareunia and Central Sensitization
Sponsor: BC Women's Hospital & Health Centre
This observational or N/A phase trial investigates Central Sensitisation and Dyspareunia and is currently completed. BC Women's Hospital & Health Centre leads this study, which shows 10 recorded versions since 2017 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Aug 2020 — Jan 2021 [monthly]
Completed
Status: Enrolling By Invitation → Completed
-
Feb 2019 — Aug 2020 [monthly]
Enrolling By Invitation
▶ Show 5 earlier versions
-
Aug 2018 — Feb 2019 [monthly]
Enrolling By Invitation
-
Jun 2018 — Aug 2018 [monthly]
Enrolling By Invitation
-
Apr 2018 — Jun 2018 [monthly]
Enrolling By Invitation
Phase: NA → None
-
Feb 2018 — Apr 2018 [monthly]
Enrolling By Invitation NA
-
Aug 2017 — Feb 2018 [monthly]
Enrolling By Invitation NA
First recorded
Jul 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- BC Women's Hospital & Health Centre
For direct contact, visit the study record on ClinicalTrials.gov .